Trials / Completed
CompletedNCT00469690
Aqueous Concentrations and PGE2 Inhibition of Ketorolac 0.4% vs. Bromfenac 0.09% in Cataract Patients: Trough Drug Effects
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 58 (actual)
- Sponsor
- Innovative Medical · Industry
- Sex
- All
- Age
- 21 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to compare the ability of two different topical NSAIDs (non-steroidal anti-inflammatory medications used for pain relief) to reach the back of the eye and to stop inflammation. The study will conclude on the day of your cataract surgery.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Acular, Xibrom | 1. Acular 5ml (in the eye)Instill one drop into the eye to be operated on four times a day at (6am, 12pm, 6pm, 12am) 2. Xibrom 5ml (in the eye) Instill one drop into the eye to be operated on two times a day (8am and 8pm) |
Timeline
- Start date
- 2007-05-01
- Primary completion
- 2008-05-01
- Completion
- 2008-05-01
- First posted
- 2007-05-04
- Last updated
- 2008-05-20
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00469690. Inclusion in this directory is not an endorsement.